GALENA BIOPHARMA INC's ticker is and the CUSIP is 363256958. A total of 3 filers reported holding GALENA BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $57,000 | -46.7% | 1,624 | -29.1% | 0.00% | -66.7% |
| Q2 2016 | $107,000 | +214.7% | 2,289 | +874.0% | 0.01% | +200.0% |
| Q1 2016 | $34,000 | -96.6% | 235 | -96.6% | 0.00% | -96.4% |
| Q4 2015 | $1,006,000 | -6.9% | 6,842 | +0.1% | 0.06% | +22.2% |
| Q3 2015 | $1,081,000 | -6.9% | 6,832 | 0.0% | 0.04% | +7.1% |
| Q2 2015 | $1,161,000 | +23.4% | 6,832 | +0.9% | 0.04% | +7.7% |
| Q1 2015 | $941,000 | -5.6% | 6,772 | +2.6% | 0.04% | +25.8% |
| Q4 2014 | $997,000 | -38.3% | 6,600 | -15.8% | 0.03% | -50.0% |
| Q3 2014 | $1,615,000 | -26.3% | 7,839 | +9.5% | 0.06% | -34.0% |
| Q2 2014 | $2,190,000 | -25.7% | 7,156 | -39.3% | 0.09% | -43.0% |
| Q1 2014 | $2,946,000 | -34.9% | 11,782 | +29.2% | 0.16% | -42.7% |
| Q4 2013 | $4,524,000 | +149.4% | 9,121 | +14.2% | 0.29% | +144.1% |
| Q3 2013 | $1,814,000 | +532.1% | 7,990 | +518.9% | 0.12% | +521.1% |
| Q2 2013 | $287,000 | – | 1,291 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 2,031,200 | $6,215,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 7,156 | $2,190,000 | 0.09% |
| Citadel Advisors | 66,700 | $204,000 | 0.00% |